This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Neuwirth, C.
Right arrow Articles by Kazmierczak, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Neuwirth, C.
Right arrow Articles by Kazmierczak, A.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, February 2000, p. 453-455, Vol. 44, No. 2
0066-4804/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

Characterization of TEM-56, a Novel beta -Lactamase Produced by a Klebsiella pneumoniae Clinical Isolate

Catherine Neuwirth,1 Roger Labia,2,* Eliane Siebor,1 Andre Pechinot,1 Stephanie Madec,2 El Bachir Chaibi,2 and Antoine Kazmierczak1

Laboratoire de Bactériologie, Hôpital Universitaire du Bocage, B.P. 1542, 21034 Dijon Cedex,1 and Centre National de la Recherche Scientifique, UMR175, 6 rue de l'Université, 29000 Quimper,2 France

Received 10 May 1999/Returned for modification 18 August 1999/Accepted 5 November 1999

TEM-56 produced by a Klebsiella pneumoniae clinical isolate is a novel beta -lactamase of isoelectric point 6.4 that confers a moderate resistance level to expanded-spectrum cephalosporins. The amino acid sequence deduced from the corresponding bla gene showed two amino acid replacements with respect to the TEM-2 sequence: Glu-104 to Lys and His-153 to Arg. This enzyme showed catalytic properties close to those of TEM-18. Thus, TEM-56 appears as a new TEM mutant, an intermediary between TEM-18 and the extended-spectrum beta -lactamase TEM-21.


* Corresponding author. Mailing address: Centre National de la Recherche Scientifique, UMR175, 6 rue de l'Université, 29000 Quimper, France. Phone: 33-2 98 90 80 35. Fax: 33-2 98 90 80 31. E-mail: roger.labia{at}univ-brest.fr.


Antimicrobial Agents and Chemotherapy, February 2000, p. 453-455, Vol. 44, No. 2
0066-4804/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Lachmayr, K. L., Kerkhof, L. J., DiRienzo, A. G., Cavanaugh, C. M., Ford, T. E. (2009). Quantifying Nonspecific TEM {beta}-Lactamase (blaTEM) Genes in a Wastewater Stream. Appl. Environ. Microbiol. 75: 203-211 [Abstract] [Full Text]  
  • De Champs, C., Chanal, C., Sirot, D., Baraduc, R., Romaszko, J. P., Bonnet, R., Plaidy, A., Boyer, M., Carroy, E., Gbadamassi, M. C., Laluque, S., Oules, O., Poupart, M. C., Villemain, M., Sirot, J. (2004). Frequency and diversity of Class A extended-spectrum {beta}-lactamases in hospitals of the Auvergne, France: a 2 year prospective study. J Antimicrob Chemother 54: 634-639 [Abstract] [Full Text]  
  • Coque, T. M., Oliver, A., Perez-Diaz, J. C., Baquero, F., Canton, R. (2002). Genes Encoding TEM-4, SHV-2, and CTX-M-10 Extended-Spectrum {beta}-Lactamases Are Carried by Multiple Klebsiella pneumoniae Clones in a Single Hospital (Madrid, 1989 to 2000). Antimicrob. Agents Chemother. 46: 500-510 [Abstract] [Full Text]